Skip to main content

Advertisement

Table 2 Clinicopathological characters of two patient groups by number of CTCs

From: Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study

Number of CTCs 0 - 4 5 ≤ P value
Number of subjects 41 24  
TNM: Stage    0.1586
Stage I 29 11  
Stage II 4 2  
Stage III 4 6  
Stage IV 4 5  
TNM: T category    0.2753
T1 26 10  
T2 5 3  
T3 5 4  
T4 5 7  
TNM: N category    0.0257 *
N0 27 12  
N1 5 0  
N2 4 2  
N3 5 10  
TNM: M category    0.2121
M0 37 19  
M1 4 5  
Main histological type    0.6844
Differentiated type 15 10  
Undifferentiated type 26 14  
Lymphatic invasion    0.3177
Lx 2 2  
L0 25 10  
L1 14 12  
Venous invasion    0.1293
Vx 2 2  
V0 26 9  
V1-2 13 13  
Surgery    0.2124
Curative resection 38 19  
Non-curative resection 1 3  
No resection 2 2  
Postoperative chemotherapy    0.1672
Presence 15 13  
Absence 26 11  
  1. * * Significant difference.